Researchers at the Baylor Research Institute gastrointestinal cancer research lab in Dallas state that early tests from trials indicate that screening checks for microRNA miR-21 in the blood "accurately spotted up to 92 percent of patients with colorectal cancer." In addition, the test also accurately identified up to 82% of patients with advanced colorectal polyps.
While physicians are cautiously optimistic with these preliminary results, this blood test would be a less invasive screening method compared to colonoscopies.
For more information about this study, click here.
No comments:
Post a Comment